Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Horizon Therapeutics (HZNP)
NASDAQ:HZNP
Holding HZNP?
Track your performance easily
HZNP Stock Chart & Stats
Day’s Range$116.26 - $116.38
52-Week Range― - ―
Previous Close$116.25
Volume28.88M
Average Volume (3M)N/A
Market Cap
$26.63B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$116.50Price Target Upside0.17% Upside
Rating ConsensusHold
Number of Analyst Covering2
Horizon Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
HZNP FAQ
What was Horizon Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Horizon Therapeutics’s market cap?
Currently, no data Available
When is Horizon Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Horizon Therapeutics’s earnings last quarter?
Currently, no data Available
Is Horizon Therapeutics overvalued?
According to Wall Street analysts Horizon Therapeutics’s price is currently Undervalued.
Does Horizon Therapeutics pay dividends?
Horizon Therapeutics does not currently pay dividends.
What is Horizon Therapeutics’s EPS estimate?
Horizon Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Horizon Therapeutics have?
Currently, no data Available
What happened to Horizon Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Horizon Therapeutics?
Among the largest hedge funds holding Horizon Therapeutics’s share is Soros Fund Mangment LLC. It holds Horizon Therapeutics’s shares valued at 339M.
---
Horizon Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$116.50 (0.17% Upside)
$116.50 (0.17% Upside)
Blogger Sentiment
Bullish
HZNP Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 5.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
Company Description
Horizon Therapeutics
Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.
---
HZNP Stock 12 Month Forecast
Average Price Target
$116.50
▲(0.17% Upside)
Best Analysts Covering HZNP
1 Year
1 Year Success Rate
20/28 ratings generated profit
1 Year Average Return
+42.89%
reiterated a buy rating 2 years ago
Copying Ken Cacciatore's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +42.89% per trade.
---